Development of therapies for hereditary diseases (Duchenne Muscular Dystrophy, Friedreich ataxia and Familial Alzheimer disease) by modifying genes with the CRISPR/Cas9 technology
CRISPR/Cas9 technology permits to target with a single guide RNA (sgRNA) a precise genomic sequence of 18 to 20 nucleotides followed by a Protospacer Adjacent Sequence (PAM). This permits ... integrin to reduce the…

